Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
Holding JANX?
Track your performance easily

Janux Therapeutics Inc (JANX) Financial Statements

237 Followers

Janux Therapeutics Inc Financial Overview

Janux Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-0.915; its P/E ratio is -52.79; Janux Therapeutics Inc is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 8.90M$ 1.25M$ 2.46M$ 2.52M$ 1.06M
Gross Profit$ 8.90M$ 1.25M$ 2.46M$ 2.52M$ 1.06M
EBIT$ -5.96M$ -20.16M$ -16.14M$ -11.57M$ -17.51M
EBITDA$ -3.67M$ -19.63M$ -15.61M-$ -18.88M
Net Income Common Stockholders$ -5.96M$ -14.76M$ -11.76M$ -11.57M$ -17.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 646.29M$ 651.76M$ 344.03M$ 349.71M$ 303.29M
Total Assets$ 691.41M$ 688.98M$ 380.41M$ 386.85M$ 341.50M
Total Debt$ 23.82M$ 24.18M$ 24.54M$ 24.89M$ 25.23M
Net Debt$ -622.47M$ -627.58M$ -319.49M$ -324.82M$ -278.06M
Total Liabilities$ 33.73M$ 33.22M$ 36.06M$ 37.90M$ 42.03M
Stockholders Equity$ 657.66M$ 655.76M$ 344.35M$ 348.95M$ 299.51M
Cash Flow-
Free Cash Flow$ -10.12M$ -15.03M$ -10.42M-$ -15.63M
Operating Cash Flow$ -10.02M$ -14.84M$ -9.90M$ -11.71M$ -15.05M
Investing Cash Flow$ -190.88M$ -113.74M$ 11.12M$ -61.45M$ 17.87M
Financing Cash Flow$ 2.77M$ 322.17M$ 831.00K$ 56.61M$ 528.00K
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Janux Therapeutics Inc Debt to Assets

Janux Therapeutics Inc Cash Flow

Janux Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis